EUVIMEDEUVIMED entdecken
Crossref

Leveraging the MMV Pathogen Box to Engineer an Antifungal Compound with Improved Efficacy and Selectivity against Candida auris

Baolong Pan, Harshini Weerasinghe, Aysha Sezmis, Michael J McDonald, Ana Traven, Philip Thompson iD, Claudia Simm iD

ACS Infectious Diseases · 2023

DOI: 10.1021/acsinfecdis.3c00199 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Infectious Diseases, 2023. Verfasst von Baolong Pan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Monash Institute of Pharmaceutical Sciences, Monash University, Parkville 3052, VIC, Australia. Hauptthemen laut MEDLINE: Antifungal Agents, Candida auris. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 84 Literaturangaben. Gefördert von: Monash University, National Health and Medical Research Council, Australian Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antifungal AgentsCandida aurisAnimalsHumansCandidaFluconazoleCandida albicansMammals

Stichwörter der Autor:innen

Candida aurisMMV Pathogen Boxantifungaldrug discoverystructure−activity relationship

Substanzen

Antifungal AgentsFluconazole

Autor:innen und Institutionen

  • Monash Institute of Pharmaceutical Sciences, Monash University, Parkville 3052, VIC, Australia.
  • Infection Program and the Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton 3800, VIC, Australia.
  • Centre to Impact AMR, Monash University, Clayton 3800, VIC, Australia.
  • School of Biological Sciences, Monash University, Clayton 3800, VIC, Australia.

ORCID-Profile: Philip Thompson, Claudia Simm

Förderung

  • Monash University
  • National Health and Medical Research Council
  • Australian Research Council

Zitieren

APA

Pan, B., Weerasinghe, H., Sezmis, A., McDonald, M. J., Traven, A., Thompson, P., & Simm, C. (2023). Leveraging the MMV Pathogen Box to Engineer an Antifungal Compound with Improved Efficacy and Selectivity against Candida auris. ACS Infectious Diseases. https://doi.org/10.1021/acsinfecdis.3c00199

Vancouver

Pan B, Weerasinghe H, Sezmis A, McDonald MJ, Traven A, Thompson P, et al. Leveraging the MMV Pathogen Box to Engineer an Antifungal Compound with Improved Efficacy and Selectivity against Candida auris. ACS Infectious Diseases. 2023. doi:10.1021/acsinfecdis.3c00199

BibTeX
@article{Pan2023,
  author = {Pan, Baolong and Weerasinghe, Harshini and Sezmis, Aysha and McDonald, Michael J and Traven, Ana and Thompson, Philip and Simm, Claudia},
  title = {Leveraging the MMV Pathogen Box to Engineer an Antifungal Compound with Improved Efficacy and Selectivity against Candida auris},
  journal = {ACS Infectious Diseases},
  year = {2023},
  doi = {10.1021/acsinfecdis.3c00199}
}
Kostenlos starten →